Appeals Court Rules Against EWTN in HHS Mandate Case
18 févr. 2016 17h20 HE
|
EWTN Global Catholic Network
Irondale, AL, Feb. 18, 2016 (GLOBE NEWSWIRE) -- This afternoon, the 11th Circuit U.S. Court of Appeals in Atlanta ruled against EWTN Global Catholic Network in its long-running battle against...
Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
04 févr. 2016 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
22 janv. 2016 09h16 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Present at Noble Financial Capital Markets’ Twelfth Annual Equity Conference
15 janv. 2016 16h31 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey’s Technology Business Tax Certificate Transfer Program
01 déc. 2015 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a specialty pharmaceutical company focused on the development and commercialization of new prescription...
Agile Therapeutics Reports Third Quarter Financial Results
09 nov. 2015 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
The Population Council and WomanCare Global Announce Worldwide License Agreement to Advance Women's Access to Innovative Contraceptive Ring
04 nov. 2015 09h15 HE
|
WomanCare Global
NEW YORK and SAN DIEGO, Nov. 4, 2015 (GLOBE NEWSWIRE) -- In a major step forward for women's health, the Population Council and WomanCare Global (WCG) today announced an exclusive worldwide licensing...
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
19 oct. 2015 16h08 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Participate at FBR Second Annual Healthcare Conference
03 sept. 2015 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial
31 août 2015 16h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...